• About us
• Contact

Advertisement

Organisation › Details

iTeos Therapeutics (Group)

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immunosuppressive pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium. *

 

	Start	2012-05-25 splitoff before
	Predecessor	Université Catholique de Louvain (UCLouvain)
	Industry	cancer immunotherapy (immuno-oncology, I-O)
	Street	45 Rue Auguste Piccard Biopark Incubator 2
	City	6041 Gosselies
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2020-06-15)
	Currency	USD
	Annual sales	4,779,000 (grant income + RnD tax credits (2019) 2019-12-31)
	Profit	-22,454,000 (2019-12-31)
	Cash	21,988,000 (2019-12-31)
		* Document for »About Section«: iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies.
		Record changed: 2024-05-14

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.